• Markets
    • icon
  • Companies
DVL · ASX

dorsaVi Ltd. (ASX:DVL)

AU$0.012

 0.0 (0.0%)
ASX:Live
25/07/2024 12:00:00 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

DVL Overview

DVL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About DVL

Website

N/A

Telephone

61.8.8360.3321

Address

Level 6 Suite 1 350 Collins Street Melbourne, Victoria (VIC) 3000

Description

dorsaVi Ltd. is a biotechnology company, which focuses on developing motion analysis device technologies for use in clinical practice, elite sports, and occupational health and safety. Its products include ViSafe, ViMove and ViPerform. The firm operates through the Clinical and Workplace segments. The company was founded by Daniel Matthew Ronchi and Andrew James Ronchi on February 18, 2008 and is headquartered in Oakleigh South, Australia.

DVL Price Chart

Key Stats

Market Cap

AU$7.38M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.03

Trade Value (12mth)

AU$2,733.00

1 week

-7.69%

1 month

9.09%

YTD

0%

1 year

-7.69%

All time high

0.54

Key Fundamentals

EPS 3 yr Growth

-88.100%

EBITDA Margin

-124.90%

Operating Cashflow

-$1m

Free Cash Flow Return

-65.00%

ROIC

-122.30%

Interest Coverage

-9.10

Quick Ratio

2.00

Other Data

Shares on Issue (Fully Dilluted)

568m

HALO Sector

Industrials

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

DVL Announcements

Latest Announcements

Date Announcements

24 July 24

dorsaVi secures commitments for $1.1m placement

×

dorsaVi secures commitments for $1.1m placement

24 July 24

Proposed issue of securities - DVL

×

Proposed issue of securities - DVL

24 July 24

Proposed issue of securities - DVL

×

Proposed issue of securities - DVL

22 July 24

Trading Halt

×

Trading Halt

15 July 24

dorsaVi completes clinical study with Norton Healthcare

×

dorsaVi completes clinical study with Norton Healthcare

14 June 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

13 June 24

Application for quotation of securities - DVL

×

Application for quotation of securities - DVL

13 June 24

Application for quotation of securities - DVL

×

Application for quotation of securities - DVL

13 June 24

Application for quotation of securities - DVL

×

Application for quotation of securities - DVL

13 June 24

Notification of cessation of securities - DVL

×

Notification of cessation of securities - DVL

13 June 24

Application for quotation of securities - DVL

×

Application for quotation of securities - DVL

13 June 24

Notification regarding unquoted securities - DVL

×

Notification regarding unquoted securities - DVL

13 June 24

Application for quotation of securities - DVL

×

Application for quotation of securities - DVL

13 June 24

Notification regarding unquoted securities - DVL

×

Notification regarding unquoted securities - DVL

13 June 24

Section 708A Cleansing Notice

×

Section 708A Cleansing Notice

27 May 24

Results of Meeting

×

Results of Meeting

21 May 24

DorsaVi AI NMA achieves gold-standard validation

×

DorsaVi AI NMA achieves gold-standard validation

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

24 April 24

Notice of General Meeting/Proxy Form

×

Notice of General Meeting/Proxy Form

24 April 24

2024 GM - Letter to Shareholders & Proxy Form

×

2024 GM - Letter to Shareholders & Proxy Form

18 April 24

Notification regarding unquoted securities - DVL

×

Notification regarding unquoted securities - DVL

16 April 24

dorsaVi enters aged care market with natural movement AI

×

dorsaVi enters aged care market with natural movement AI

15 April 24

Non-executive Director resignation

×

Non-executive Director resignation

15 April 24

Final Director's Interest Notice

×

Final Director's Interest Notice

08 April 24

dorsaVi releases video AI for upper limb tracking

×

dorsaVi releases video AI for upper limb tracking

DVL Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.00 -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 75.7 46.2 9.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.01 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 33.5 -0.8 53.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -29.0 -52.4 -19.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 272.2 -51.1 -10.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 301 358 467 Lock Lock Lock
Basic m Lock Lock Lock Lock 301 358 467 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 2 2 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.4 25.9 -25.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 1 1 2 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 21.3 16.6 45.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -93.2 -61.7 -45.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 193 162 146 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -3 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.8 7.8 17.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -153.7 -112.5 -124.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -3 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 22.2 8.2 16.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -164.9 -120.2 -135.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -2 -2 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -1 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -2 -2 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 68.2 36.3 -18.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -129.1 -65.3 -104.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -2 -2 -1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 3 0 1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -2 -2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -6.3 4.5 55.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.2 -0.9 -0.6 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 3 0 1 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 5 3 3 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -2 1 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 2 1 Lock Lock Lock
Equity $m Lock Lock Lock Lock 2 1 2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 3 1 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 58.1 -60.4 32.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -44.5 -45.8 -67.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -97.4 -125.8 -108.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -84.2 -90.3 -107.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -74.6 -64.1 -122.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -70.2 -89.9 -65.0 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -8.6 -6.8 -9.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.6 -0.3 0.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -65.1 59.9 -33.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.4 1.5 2.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 2.1 1.2 2.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 58.2 14.7 34.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -113.6 -104.1 -98.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.5 1.9 1.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 5.8 6.6 4.9 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.7 2.4 1.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 4.0 3.3 2.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.7 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.7 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -151.5 -89.2 -131.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -52.2 -62.5 -85.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -44.5 -45.8 -67.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.2 2.7 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -97.4 -125.8 -108.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -97.4 -125.8 -108.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 63.3 55.1 75.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 241.6 189.4 224.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 305.0 244.4 300.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 7.6 7.5 8.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 297.4 236.9 291.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

DVL Shortsell

Frequently Asked Questions

The current share price of dorsaVi Ltd. (DVL:ASX) is AU$0.012.
The 52-week high share price for dorsaVi Ltd. (DVL:ASX) is AU$0.03.
The 52-week low share price for dorsaVi Ltd. (DVL:ASX)? is AU$0.01.
dorsaVi Ltd. (DVL:ASX) does not pay a dividend.
dorsaVi Ltd. (DVL:ASX) does not pay a dividend.
dorsaVi Ltd. (DVL:ASX) has a franking level of 0.0%.
dorsaVi Ltd. (DVL:ASX) is classified in the Industrials.
The current P/E ratio for dorsaVi Ltd. (DVL:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.